Science Explorer Interactive view Map
Company · Warsaw · Poland

Celon Pharma (Poland)

celonpharma.com/enROR OpenAlex
Research works
66
▲ 197% vs 2013–17
Citations
624
9.5 per fractional work
Top-10% rate
6.5%
record average 16.5%
Open access
58%
world 28%

Not ranked overall: Celon Pharma (Poland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.52× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.17× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 6.85× its world share, 2 worksImmunology and Micro…Neuroscience: 2.20× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.55× its world share, 0 worksPharmacology, Toxico…Chemistry: 5.79× its world share, 2 worksChemistryComputer Science: 0.72× its world share, 1 worksComputer ScienceEngineering: 0.20× its world share, 1 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.99× its world share, 1 worksMaterials ScienceMedicine: 1.61× its world share, 8 worksMedicineEconomics, Econometrics and Finance: 0.40× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.8×. Every wedge is a field page.

Which keywords describe research at Celon Pharma (Poland)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Glycosylation, Metabolism, Signaling, Medicinal Chemistry, Monoclonal Antibodies, Obesity and Development.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Cancer4▲ 10×7 topics
  2. Glycosylation2▲ 81×2 topics
  3. Metabolism2▲ 16×2 topics
  4. Signaling2▲ 150×2 topics
  5. Medicinal Chemistry2▲ 29×4 topics
  6. Monoclonal Antibodies2▲ 88×2 topics
  7. Development2▲ 22×2 topics
  8. Obesity2▲ 10×3 topics
  9. FGF212▲ 601×1 topic
  10. Fibroblast Growth Factor2▲ 601×1 topic
  11. Fc Receptors2▲ 129×1 topic
  12. Therapeutic Antibodies2▲ 101×1 topic
  13. Machine Learning2▲ 1.93×2 topics
  14. Drug Discovery1▲ 23×3 topics
  15. Immune Regulation1▲ 48×2 topics
  16. Inflammation1▲ 2.5×6 topics
  17. Molecular Docking1▲ 44×1 topic
  18. Virtual Screening1▲ 60×1 topic
  19. CD471▲ 279×1 topic
  20. Tumor Microenvironment1▲ 11×4 topics
  21. apoptotic cells1▲ 279×1 topic
  22. Therapeutic Targets1▲ 27×4 topics
  23. Biomedical Applications1▲ 3.2×2 topics
  24. Oxidative Stress1▲ 2.4×6 topics

Which research topics does Celon Pharma (Poland) publish most on?

By volume in 2022–2025: Fibroblast Growth Factor Research, Monoclonal and Polyclonal Antibodies Research, Computational Drug Discovery Methods and Phagocytosis and Immune Regulation.

Fibroblast Growth Factor Research: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksComputational Drug Discovery Methods: 1 fractional worksPhagocytosis and Immune …1Phagocytosis and Immune Regulation: 1 fractional worksInnovative Microfluidic and Catalytic Techniques Innovation: 1 fractional worksMetabolomics and Mass Spectrometry Studies: 1 fractional worksChemical Synthesis and Analysis: 1 fractional worksReceptor Mechanisms and Signaling: 1 fractional worksNitric Oxide and Endothelin Effects: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional works
Molecular BiologyRadiology, Nuclear Medicine and ImagingComputational Theory and MathematicsImmunology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Fibroblast Growth Factor Research Molecular Biology 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  4. 4 Phagocytosis and Immune Regulation Immunology 1 works
  5. 5 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 1 works
  6. 6 Metabolomics and Mass Spectrometry Studies Molecular Biology 1 works
  7. 7 Chemical Synthesis and Analysis Molecular Biology 1 works
  8. 8 Receptor Mechanisms and Signaling Molecular Biology 1 works
  9. 9 Nitric Oxide and Endothelin Effects Physiology 0 works
  10. 10 Chronic Lymphocytic Leukemia Research Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.5%not open42.5%

World: 28% of research is openly available.

with international co-authors13.9%domestic only86.1%

World: 19% is written across borders.

How has Celon Pharma (Poland)'s research output changed?

Output in 2018–2022 was 197% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Warsaw

All research institutions in Warsaw

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.